ストックスクリーナーアプリを入手
11.84
3.00%
0.345
Roivant Sciences Ltd (ROIV) 最新ニュース
Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution - Yahoo Finance
Principal Financial Group Inc. Trims Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Andreas Halvorsen's Recent Transaction in Roivant Sciences Ltd - GuruFocus.com
Roivant Sciences Ltd. (ROIV) Quarterly 10-Q Report - Quartzy
Vivek Ramaswamy: 10 things you ought to know about Trump's DOGE co-lead - MSN
Roivant Sciences Ltd - Reuters.com
Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Trump’s appointment of Ramaswamy sparks speculation on Korean biotech firms linked to Roivant - KBR
Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE) - MSN
From Vadakkanchery to top US Govt post: Vivek Ramaswamy's Kerala roots - Mathrubhumi English
The Analyst Landscape: 5 Takes On Roivant Sciences - Benzinga
How Vivek Ramaswamy Became A Billionaire - Forbes
Who is Vivek Ramaswamy? What to know about Cincinnati billionaire part of Trump's Cabinet - The Cincinnati Enquirer
Vivek Ramaswamy Net Worth 2024: How He Built a Billion-Dollar Empire - Black Star News
Vivek Ramaswamy's journey from bright son of immigrants to being Donald Trump's pick - The Economic Times
Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript - Insider Monkey
Vivek Ramaswamy Net Worth 2024: Salary, Net Worth in Rupees (INR), Annual Income, Houses, and Cars. - Jagran Josh
Who Is Vivek Ramaswamy, The Biotech Entrepreneur Now Part Of Trump 2.0 - NDTV
Vivek Ramaswamy Net Worth: How this key Trump aide built his billion-dollar empire - Moneycontrol
Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new 'Department of - The Times of India
Roivant Sciences Ltd (ROIV) Q2 2024 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
Vivek Ramaswamy Net Worth: From Transforming 'Ailing' Pharma To Betting On Crypto; How Trump’s Key Aide Built His Empire - Jagran English
FMR LLC Bolsters Stake in Roivant Sciences Ltd - GuruFocus.com
Roivant Sciences Reports Q2 2024 Financial Results - TipRanks
Roivant Sciences earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Vivek Ramaswamy's Net Worth: How Harvard-Yale graduate became rich by selling 'sick' pharma companies - The Economic Times
Vivek Ramaswamy Net Worth: How Much Money Does the Co-Director of D.O.G.E Have? - Revista Merca2.0
Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 2c - StreetInsider.com
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update - The Manila Times
Roivant Sciences Ltd (ROIV) Q2 2025 Earnings Report Preview: Wha - GuruFocus.com
ROIVWroivw Latest Stock News & Market Updates - StockTitan
Vanguard Group Inc's Strategic Acquisition in Roivant Sciences L - GuruFocus.com
Roivant Sciences (ROIV) to Release Earnings on Tuesday - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Acquired by Impax Asset Management Group plc - MarketBeat
Allspring Global Investments Holdings LLC Sells 115,694 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024 - Yahoo Finance
Organon Completes Acquisition of Dermavant - njbmagazine.com
China Universal Asset Management Co. Ltd. Boosts Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Organon completes Dermavant Sciences acquisition By Investing.com - Investing.com Canada
Organon completes Dermavant Sciences acquisition - Investing.com
Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% - StockTitan
At Roivant Sciences, Eric Venker Chooses To Exercise Options, Resulting In $782K - Benzinga
Options Exercise: Eric Venker At Roivant Sciences Realizes $782K - Benzinga
Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 100,000 Shares - MarketBeat
Roivant Sciences president sells $1.17 million in shares By Investing.com - Investing.com Australia
Roivant Sciences president sells $1.17 million in shares - Investing.com
Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility (ROIV) - Seeking Alpha
Leerink maintains outperform on Roivant with steady target By Investing.com - Investing.com Australia
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):